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Background: Medication adherence is crucial for positive outcomes in the management of
chronic conditions. Comprehensive medication consultation can improve medication adherence
by addressing intentional and unintentional nonadherence. The Medicare Part D prescription
drug benefit has eliminated some cost barriers. We sought to examine variables that impact
self-reported medication adherence behaviors in an ambulatory Medicare-beneficiary population and to identify the factors that influence what information is provided during a pharmacist
consultation.
Methods: Medicare beneficiaries who attended health fairs in northern California were offered
medication therapy management (MTM) services during which demographic, social, and health
information, and responses to survey questions regarding adherence were collected. Beneficiaries were also asked which critical elements of a consultation were typically provided by
their community pharmacist. Survey responses were examined as a function of demographic,
socioeconomic, and health-related factors.
Results: Of the 586 beneficiaries who were provided MTM services, 575 (98%) completed the
adherence questions. Of responders, 406 (70%) reported taking medications “all of the time”. Of the
remaining 169 (30%), the following reasons for nonadherence were provided: 123 (73%) forgetfulness; 18 (11%) side effects; and 17 (10%) the medication was not needed. Lower adherence rates
were associated with difficulty paying for medication, presence of a medication-related problem,
and certain symptomatic chronic conditions. Of the 532 who completed survey questions regarding
the content of a typical pharmacist consultation, the topics included: 378 (71%) medication name
and indication; 361 (68%) administration instructions; 307 (58%) side effects; 257 (48%) misseddose instructions; and 245 (46%) interactions. Subsidy recipients and non-English speakers were
significantly less likely to be counseled on drug name, indication, and side effects. The presence
of certain health conditions was also associated with missing consultation elements.
Conclusion: While Medicare beneficiaries are generally adherent to medication therapy,
adherence barriers must be identified and addressed during comprehensive medication
consultation.
Keywords: pharmacist consultation, adherence behaviors
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In 2003, the World Health Organization produced a report entitled “Adherence to
Long-Term Therapies: Evidence for Action”, in which the average adherence rate
to therapies for chronic conditions in developed countries was a sobering 50%.1 The
report emphasized that the cause of poor adherence does not reside with the patient
but rather, with the health system. It identified the importance of a health care team
that includes the patient and that has training in adherence strategies. The report also
called for additional assessments, not only of adherence rates, but also, of the factors that impact it. Adherence rates in the Medicare population have already been
examined. In 2013, a report was published regarding medication adherence in all
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50 States. In addition to other adherence measures, medication possession ratios, defined as the ratio of the total days
the member had drug available to the number of possible
days the member could have drug on hand, were reported.2
The report provided a state-wide average, adjusted for age
and sex. The results provide a comparison of adherence rates
in three distinct market segments: Medicare Part D (MPD)
beneficiaries, employer health plan holders, and personal
health plan holders. Adherence rates were highest in the
MPD population.
Poor adherence increases the risk of morbidity, hospitalization, and mortality, thus has clear implications for worsening
health outcomes as well as increasing health care costs.3 In four
common conditions – hypertension, diabetes, hyperlipidemia,
and heart failure – higher levels of medication adherence have
been found to be associated with lower hospitalization rates.4
Medication nonadherence has been estimated to cost the health
care system approximately $100 billion in hospitalizations
annually and $2,000 per patient year in excess physician visits.5
An estimate of excess health care costs in the United States due
to medication nonadherence approaches $290 billion annually.6 In a review of the predictors of adherence, Touchette and
Shapiro reported that lower adherence rates are associated with
increased complexity of the drug regimen and other factors,
including number of medications, poor patient–provider relationship, lower socioeconomic status, poor prescription drug
coverage, presence of medication side effects, living alone,
and treatment of asymptomatic conditions and specific health
conditions, such as depression and cognitive impairment.7
Other risk factors associated with poor adherence include
confusion or forgetfulness, language barriers, and “feeling
well enough to forgo taking the medication”.6 Medication cost,
including copayments, contributes to medication nonadherence in uninsured, elderly, indigent, and homeless populations,
but also, in middle-income patients with prescription coverage
and Medicare recipients.8–11
In 2006, the MPD benefit was introduced to help beneficiaries pay for their outpatient prescription medications.
However, with the advent of MPD, may have come complacency with respect to the identification and resolution of
cost-related barriers to medication adherence. Beneficiaries
of MPD may still have difficulty with their medication costs
and may therefore benefit from additional governmental
assistance, either Medicaid or the Low-Income Subsidy. In
this manuscript, subsidy recipients refers to those beneficiaries who had either Medicaid or the Low-Income Subsidy.
While MPD removed many cost related barriers to medication adherence, it also created one for beneficiaries who enter
the coverage gap known as the “Donut Hole” – during this
1278
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time, many patients become nonadherent to their medication
therapy, as they are unable to pay for their share of prescription costs.12 In 2013, there were over 50 million Medicare beneficiaries, and this number is projected to grow to 72 million
by 2030.13 Considering that Medicare beneficiaries who
qualify for coverage based on their age (65+ years of age)
take a significant number of medications in comparison with
other age groups, it is critical to focus on this population in
order to identify and solve issues relating to nonadherence.
Nonadherence can be classified as either unintentional or
intentional. Unintentional nonadherence refers to a patient
forgetting to take their medication(s), while intentional
nonadherence refers to the patient weighing the pros and
cons of taking a medication, and consciously deciding not to
adhere to the medication regimen.14 Pharmacist consultation
provides patients with information and strategies to optimize
medication-related outcomes. Both types of nonadherence
require distinct methods to address and correct the issue.14,15
A previous review of medication adherence from the pharmacist perspective discussed mechanisms for assessing
adherence and persistence, and strategies for improving adherence.16 While many sophisticated and expensive methods of
monitoring adherence are available, patient self-reporting
remains the most common and least expensive means of
assessing adherence. The factors impacting adherence that
were discussed in the review included adverse effects of medication, perceived lack of effect, complexity of the regimen,
asymptomatic conditions, physical limitations, psychiatric
conditions, individual perceptions, family or cultural issues,
and functional health literacy. The authors concluded that
regardless of the various factors that contribute to nonadherence, effective communication between the pharmacist,
patient, and other health care providers is critical. Use of
open-ended questions in discussions, patient education on
key consultation points, and provision of follow up was recommended. The authors further concluded that clarification
of instructions, particularly for the elderly or patients with
cognitive impairment, and scheduled follow up is essential.
Optimal health care requires a team-based approach, and
pharmacists are recognized as an integral part.17 Pharmacists
are ideally situated to provide consultation to patients in the
community setting. A comprehensive meta-analysis regarding
the effects of pharmacist-provided patient care showed statistically significant beneficial outcomes in all three domains
of therapeutic, safety, and humanistic outcomes, including
medication adherence.18 Patients indicated that the top consultation elements expected to be provided during their medication consultation included adverse effects, directions for use,
drug interaction with prescription drugs, drug indication, and
Patient Preference and Adherence 2014:8
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special instructions for unique prescriptions.19,20 However,
deficiencies in patient consultation may translate to medication nonadherence. Studies conducted to examine this issue
have identified several barriers that prevent patients from
asking their pharmacists for a consultation. Patient barriers
include fear of embarrassment, time constraints, and lack of
initiative, education, or perceived need. In some cases, patients
indicated that they trusted the physician to provide the needed
information or that written information would be adequate.
Lastly, the pharmacy may lack privacy or the pharmacist may
be perceived as unapproachable.19–22 In order to decrease unintended medication-related outcomes and increase medication
adherence, further examination of pharmacists’ consultation
from the patient’s perspective is critical.
The objective of this study was to determine variables
that impact self-reported medication adherence behaviors
in an ambulatory Medicare population. Since nonadherence
can be impacted by knowledge of the medication, factors that
impact information provided during pharmacist consultations
with this population were also examined.

Methods
This study was conducted with the approval of the Institutional Review Board of the University of the Pacific. Twelve
community outreach events were conducted during the 2013
MPD Open Enrollment Period in six central and northern
California cities. Medication therapy management (MTM)
was offered to all beneficiaries taking at least one medication.
MTM was conducted by student pharmacists under the supervision of licensed pharmacists. During MTM, patients were
asked to provide verbal informed consent and were invited
to answer a series of survey questions asked by student pharmacists. Participants were given the option of not answering
each of the questions and were informed that they could stop
answering questions at any time and still receive all services,
without penalty. A standardized data collection tool was used
to collect demographic information, social history, subsidy
status, and medication and disease state information, and
to document answers to survey questions. Each beneficiary
was asked “Which of the following best describes how often
you take your medications as directed”. Answer options
included: “all of the time”; “most of the time”; “some of the
time”; and “none of the time”. A beneficiary who responded
with anything other than “all of the time”, was then asked
“What is/are the main reason(s) that you do not take your
medication as directed?” The respondent could select any (or
all) option(s) that applied from the following, including: “I
forget to take my medications”; “I do not get my medication
refilled on time”; “I experience side effects”; “I do not know
Patient Preference and Adherence 2014:8
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what the medication is for”; “I do not think I need it”; “I do
not think it is helping me”; “I want to save some for later”;
or “I cannot afford it”.
Next, an assessment of critical elements of pharmacist
consultation was conducted. Beneficiaries were asked
“Which of the following is typically discussed in a consultation with your pharmacist?” Beneficiaries answered “yes”
or “no” to each element. The elements included: “What the
medication is called and what it is used for”; “How and when
you should take it and for how long”; “What you should do if
you miss a dose”; “What the side effects are”; and “Whether
it is safe to take with other medicines or vitamins”.
Descriptive statistics were reported for beneficiary demographic and clinical characteristics. Each demographic and
clinical characteristic was analyzed to determine its effect
on adherence. Chronic conditions were also evaluated to
determine their association with self-reported adherence. Chisquare and Fisher’s exact tests were used for each variable, to
compare those who reported taking medication all of the time
with those who reported taking medication less than all of the
time. The Mann–Whitney test was used to evaluate the effects
of self-reported adherence as a function of level of education,
number of chronic medications, and number of chronic conditions. Variables that could impact whether critical consultation
elements were provided were also analyzed using inferential
statistics. Chi-square and Fisher’s exact tests were used to
examine the differences in what was typically discussed during
a pharmacist consultation as a function of demographic and
clinical characteristics. Alpha was set a priori to 0.05. Statistics were performed via IBM SPSS Statistics for Windows,
Version 20 (IBM Corp, Armonk, NY, USA).

Results
A total of 1,547 Medicare beneficiaries attended the outreach
events; of those, 586 were provided MTM services. Of the
beneficiaries who were provided MTM services, 575 (98%)
completed the questions regarding medication adherence,
and 532 (91%) completed the survey questions regarding
pharmacist consultations. Demographic and clinical characteristics are provided in Table 1.
When asked about medication adherence, 406 (71%)
reported taking their medication “all the time”, 143 (25%)
reported taking their medication “most of the time”, and
26 (4%) reported taking their medication “some of the time”.
No individuals reported taking their medication “none of
the time”. For the 169 (29%) beneficiaries who reported
not taking medication all of the time, the reasons given
are summarized in Table 2. Statistical analysis identified
that difficulty paying for medications and the presence of
submit your manuscript | www.dovepress.com
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Table 1 Demographics and clinical characteristics (N=586)
Sex, n (%) (N=566)
Female

353 (62.4%)

Male

213 (37.6%)

Patient Preference and Adherence downloaded from https://www.dovepress.com/ by 138.9.41.109 on 03-Mar-2017
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Age, n (%) (N=550)
65 years

36 (6.5%)

65–74 years

240 (43.6%)

75–84 years

169 (30.7%)

85 years

105 (19.1%)

Race/ethnicity, n (%) (N=564)
White

352 (62.4%)

Non-white

212 (37.6%)

Hispanic, n (%) (N=561)
No

511 (91.1%)

Yes

50 (8.9%)

Preferred language, n (%) (N=570)
English

407 (71.4%)

Non-English

163 (28.6%)

Marital status, n (%) (N=564)
Married

292 (51.7%)

Widowed

159 (28.2%)

Divorced/separated

59 (10.5%)

Single

54 (9.6%)

Highest level of education completed, n (%) (N=557)
Grade 8 or less

58 (10.4%)

Some high school (grade 9–12)

45 (8.1%)

High school diploma or equivalent

94 (16.9%)

Some college or associate degree

134 (24.1%)

Bachelor’s degree or higher

226 (40.5%)

Prescription drug coverage type, n (%) (N=543)
Medicare Part D stand-alone prescription drug plan

383 (70.5%)

Medicare advantage prescription drug plan

81 (14.9%)

Creditable coverage

46 (8.5%)

No coverage

33 (6.1%)

Prescription drug subsidy status, n (%) (N=436)
Non-subsidy recipients

285 (62.5%)

Subsidy recipients (ie, Medicaid or Low-Income Subsidy)

171 (37.5%)

Reported difficulty paying for medication, n (%) (N=456)
No

401 (92.0%)

Yes

35 (8.0%)

Prescriptions, n (%) (N=531)
0–2

115 (21.7%)

3–4

132 (24.9%)

5–6

118 (22.2%)

6

166 (31.2%)

Chronic conditions, n (%) (N=582)
0–2

162 (27.8%)

3–4

195 (33.5%)

5–6

132 (22.7%)

6

93 (16.0%)

Medication-related problem identified during medication therapy management, n (%) (N=586)
No

225 (38.4%)

Yes (total)

361 (61.6%)

Yes (severe enough to prompt communication with prescriber)

71 (12.1%)
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Table 2 Reported reasons for medication nonadherence (N=169)
Reason stated

N (%)*

Forget to take
Worrisome side effect
Do not think it is needed
Other
Did not get refill in time
Cannot afford it
Do not think it is helping
Do not know what it is for
Wanted to save some for later

123 (72.8%)
18 (10.7%)
17 (10.1%)
13 (7.7%)
7 (4.1%)
7 (4.1%)
2 (1.2%)
1 (0.6%)
1 (0.6%)

Note: *Participants could select more than one reason for medication nonadherence.

s pecific symptomatic medical conditions were associated
with medication nonadherence. Additionally, beneficiaries
for whom a medication-related problem was identified during
the MTM session were found to be significantly less likely
to be adherent with their medication(s). The factors that
were statistically significantly associated with suboptimal
medication adherence are shown in Table 3.
Beneficiaries reported that critical elements were included
in a typical pharmacist consultation between 46% and 71% of
the time (Table 4). There was no statistically significant difference between sex, race/ethnicity, education level, prescription
drug coverage type, number of prescription medications, or
the presence of chronic conditions, such as hypertension,
hyperlipidemia, or diabetes mellitus, in relation to pharmacist
consultative elements. Subsidy recipients were less likely
to report receiving elements of the pharmacist consultation,
including medication name and indication (P=0.008) and
consultation about side effects (P=0.006). Beneficiaries
who spoke a language other than English were less likely to
receive consultation regarding medication name and indication
(P=0.014) or consultation about side effects (P=0.009). Further
analysis revealed that beneficiaries who were subsidy recipients were significantly more likely to be non-English speakers (P0.001). Certain health conditions, including benign
prostatic hypertrophy, cancer, incontinence, and dementia,
were associated with significantly more missing elements of
Table 3 Factors associated with lower self-reported medication
adherence
Variable

P-valuea

Difficulty paying for medications
Medication-related problem identified during
medication therapy management
Beneficiaries with gastroesophageal reflux disease
Beneficiaries with coronary heart disease
Beneficiaries with asthma
Beneficiaries with anxiety
Beneficiaries with allergic rhinitis

0.01
0.008

Note: aPearson’s chi-square.

Patient Preference and Adherence 2014:8

0.005
0.012
0.007
0.01
0.002

the pharmacist consultation. In addition, our research identified
that advancing age was associated with more missing elements
for all critical components of the pharmacist consultation,
some reaching statistical significance (Table 5).

Discussion
In our study population, level of education, sex, age, marital status, race/ethnicity, number of chronic medications or
conditions, preferred language, or subsidy status were not
significantly associated with self-reported medication adherence. Our findings may differ from those of other studies in
that within our population, less than 7% were younger than
65 years, and 40% reported obtaining a bachelor’s degree or
higher. Three factors were statistically associated with less
than optimal adherence. These included some symptomatic
conditions, issues related to paying for medication, and identifying medication-related problems during MTM. Our study
identified an association between lower adherence rates in
beneficiaries with symptomatic conditions, such as gastro
esophageal reflux disease, coronary heart disease, asthma,
allergic rhinitis, and anxiety. In our population, there was no
association with depression or asymptomatic conditions, such
as hyperlipidemia or hypertension and poor adherence, contrary to findings reported elsewhere.7 It is possible that some
patients with symptomatic conditions may be inclined to take
prescribed medications when experiencing symptoms, rather
than routinely as prescribed. In order to ensure that patients
are adherent for chronic but episodically symptomatic conditions, pharmacists should include the reason the drug is being
prescribed as part of the consultation. In our study population,
70% of patients recalled that drug name and indication were
included in the pharmacist consultation. Among, the participants in our study population who reported taking their medication less than all of the time, thinking that the medication
was not needed was reported as one of the top three reasons.
Another study has reported that the primary reason for intentional nonadherence was a belief that the medication is not
needed.23 Without a clear understanding of the purpose of the
medication, patients may fail to adhere properly and eventually
require emergent care or hospitalizations, to manage a poor
medication outcome caused by intentional nonadherence.
Cost of medication, even with the MPD prescription drug
benefit, was a barrier to adherence in our study population.
This finding is consistent with those reported by others.11,16
In terms of overcoming cost barriers that lead to medication
nonadherence, pharmacists or other patient advocates can
provide assistance by ensuring that individuals are in the lowest MPD cost plan, enrolling beneficiaries into pharmaceutical assistance programs, or assisting individuals to apply for
submit your manuscript | www.dovepress.com
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Table 4 Effects of chronic diseases on information provided during pharmacist consultation: percent of Medicare beneficiaries who
reported they received consultation elements

Overall population
Beneficiaries with cancer
Beneficiaries with incontinence
Beneficiaries with benign prostatic hypertrophy
Beneficiaries with dementia

Drug name and
indication

How to
take

Missed
dose

Side effects

Safe to take with
other medicine

71%
69%
64%
56%d
50%e

68%
53%a
55%
58%
50%

48%
47%
32%b
44%
20%f

58%
49%
48%
48%
37%

46%
40%
30%c
40%
32%

Notes: Pearson’s chi-square. aP=0.046. bP=0.017. cP=0.023. dP=0.019. eP=0.035. fP=0.009.

the Low-Income Subsidy. Approximately 90% of Medicare
beneficiaries could reduce their out-of-pocket prescription
drug costs by annually reviewing their MPD plan.24
The patients in our study who had a medication-related
problem identified during the MTM process were statistically
more likely to report less than optimal adherence. Experiencing a worrisome side effect was the second most common
reason stated for nonadherence in our population. Beneficiaries in this study were offered MTM if they were taking
one or more medications. The current inclusion criteria for
MTM from the Centers for Medicare and Medicaid (CMS)
allow MPD plan sponsors to require that patients take up to
eight medications in order to meet the drug requirement for
provision of MTM services.25 CMS data from 2012 reveal
that 75% of MPD plan sponsors required a beneficiary to be
taking seven or eight medications to qualify for MTM. The
ability of pharmacists to provide MTM to a greater number
of Medicare beneficiaries and therefore identify and resolve
medication-related problems has the potential to improve
adherence.26 A recent brief from the New England Healthcare Institute acknowledged the value of MTM to improve
adherence and, ultimately, health care outcomes but recognized the hesitance from stakeholders, particularly payers,
to implement MTM on a broader scale.27
Advancing age was associated with lower reported rates
of comprehensive consultation. Considering that most Medicare beneficiaries are over the age of 65 years, it is possible
that our findings may reflect memory decline associated with
advancing age or dementia and that beneficiaries did not
recall elements covered in the consultation, or that advancing

age impacts what pharmacists discuss in a consultation.
Forgetting to take medication was the most common reason
for nonadherence reported by our study participants. One
study reported that 70% of community dwelling seniors use
a pillbox.28 Memory aids, medication reminders, and other
adherence strategies should be offered, to minimize this
form of unintentional nonadherence. Subsidy recipients and
MDP beneficiaries who spoke a language other than English
were less likely to receive elements of the pharmacist consultation; however, further analysis revealed that beneficiaries
who were subsidy recipients were significantly more likely to
be non-English speakers, suggesting it may be the language
barrier that produced the results.
Our research identified that although pharmacists generally include essential information that patients desire during
a consultation, critical elements of medication consultation
were omitted between 29% and 52% of the time. Pharmacist
discomfort or lack of privacy may be contributing to the omission of consultation elements for specific conditions such as
dementia, incontinence, and benign prostatic hypertrophy.
Our research also found that patients with cancer were less
likely to be counseled on how to take the drug and for how
long. This may relate to a lack of knowledge by pharmacists
about cancer therapy regimens.29
Considered to be the most accessible of the health care
providers, pharmacists play an important role in the management of patients’ health, particularly as it relates to the
medication regimen. In a published review of medication
adherence from the pharmacist perspective, recommended
strategies to improve adherence include ensuring effective

Table 5 Effect of age on information provided during pharmacist consultation: Percentage of Medicare beneficiaries in each age category
who reported they received consultation elements
Element of consultation

65–74 years

75–84 years

85 years

P-valuea

Drug name and indication
How to take
Missed dose
Side effects
Safe to take with other medicine

78%
76%
54%
63%
52%

68%
67%
46%
57%
46%

63%
52%
39%
46%
35%

0.038
0.001
0.055
0.049
0.080

Note: aMann–Whitney.
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communication between the pharmacist, patient, and
providers; use of nonjudgmental, open discussions; provision
of clarifying instructions; and use of scheduled follow up, to
provide additional support.16
In our population, mechanisms to enhance adherence could
include medication education, medication reminders, elimination of cost barriers, and identification and resolution of side
effects or other medication-related problems. Considering there
are two types of nonadherence, intentional and unintentional,
mechanisms to overcome barriers must be tailored to the cause.
By using an empathic, patient-centric communication style,
clinicians may be more effective in identifying the presence
of intentional and unintentional nonadherence and tailoring
interventions to the needs of patients.15

Limitations
There are several limitations to this study. The use of a survey
to assess adherence relied on study participants’ self-reported
behavior; objective measurements or validation of actual
adherence rates were not conducted as our objective was to
identify variables associated with nonadherence, rather than to
determine adherence rates. Self-reported adherence data gathered from patient interviews have historically overestimated
adherence rates.16 Our survey was not a validated or commercially available tool. While a validated adherence assessment questionnaire could have been used to determine the
adherence rate, additional questions would have to have been
asked in order to identify other variables associated with nonadherence. The Medication Adherence Questionnaire (MAQ)
is a validated tool most commonly used because of its short
length, ease of scoring, and previous validation in patients
with a variety of chronic conditions.30,31 Our survey included
variables that are assessed by the MAQ, such as forgetfulness,
beliefs about the need for the medication, and presence of
adverse effects, but we added items, including being unable
to afford the medication. We did not assess adherence to
individual medication but rather, to the medication regimen
in general and thus are unable to make determinations about
adherence variables for individual medications.
Study participants were asked about a typical community
pharmacist consultation. Again, this process relied on the
individual’s ability to recall what was included in the consultation, introducing potential recall bias. Direct observation
of pharmacists’ consultations was not done. Nonetheless, the
provision of patients’ perspectives on what they remember from
a consultation is an important contribution to the literature.
Our study surveyed Medicare beneficiaries from one
geographic area that included northern and central California.
Our population was predominantly white, and 40% reported
Patient Preference and Adherence 2014:8
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attaining a college degree. Thus the applicability of our
findings to other Medicare populations may be limited.
The study identified factors in a Medicare population that
were statistically associated with reduced adherence as well as
noncomprehensive consultation by pharmacists. An examination
of the effectiveness of interventions to enhance adherence is
needed. Comprehensive consultation by pharmacists for all beneficiaries is desirable, but systematic supports, such as improved
privacy, resources for consultations conducted in languages other
than English, and strategies for effective targeting of unintentional nonadherence related to forgetfulness are needed.

Conclusion
This study adds to our understanding of self-reported adherence behaviors in an ambulatory Medicare population. The
30% of Medicare beneficiaries in our study population who
reported not taking medication as prescribed all of the time provided reasons and thus, opportunities to enhance medication
adherence. The top three reasons for nonadherence included
forgetting to take medication, not taking medication due to
a worrisome side effect, and belief that the medication was
not needed. A statistical analysis identified factors that were
associated with medication nonadherence, including patients
with specific health conditions, patients who had a medicationrelated problem identified during medication therapy management, and those who reported difficulty paying for medication,
even with the MPD benefit. While Medicare beneficiaries
are generally more adherent to medication therapy than other
groups, barriers must be identified and addressed. An effective,
comprehensive pharmacist consultation could successfully
address many of these barriers and provide an opportunity
to optimize drug therapy outcomes. Our study revealed that
limited economic means (Medicaid or Low-Income Subsidy recipients) and preferred language other than English
were associated with lower rates of consultation discussion
regarding drug name and indication, and side effects. Further
research is required to examine factors that lead to nonadherence and to assess the effectiveness of interventions designed
to improve patient well-being and avoid unnecessary health
care spending. Next steps should include examination of
the effectiveness and acceptability of different memory aids
in the Medicare population, a prospective examination of
which counseling elements are being covered in a pharmacist
consultation for this population, and lastly, examination of how
often the consultation elements should be repeated to optimize
retention and thus, support optimal adherence.
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